RT @carvicab: No alcance a ver al ministro @agaviriau .Falta más discusión de fondo, la intención es buena https://t.co/5F7ILUq0tw https://…
RT @carvicab: No alcance a ver al ministro @agaviriau .Falta más discusión de fondo, la intención es buena https://t.co/5F7ILUq0tw https://…
RT @carvicab: No alcance a ver al ministro @agaviriau .Falta más discusión de fondo, la intención es buena https://t.co/5F7ILUq0tw https://…
No alcance a ver al ministro @agaviriau .Falta más discusión de fondo, la intención es buena https://t.co/5F7ILUq0tw https://t.co/GJ3HZLKGSA
RT @PanlarLeague: Provechosa entrevista con @FioAlvarado del canal 11 en Costa Rica sobre #Biosimilares https://t.co/Tyl7w9yiGk https://t…
Provechosa entrevista con @FioAlvarado del canal 11 en Costa Rica sobre #Biosimilares https://t.co/Tyl7w9yiGk https://t.co/3g5lmD5WdE
Coming back from #FLAB2016 Great discussions on the recommendations to ensure safety & effectiveness of Biosimilars https://t.co/lgYtVFyLG5
@RheumJC Real efforts should be made in the pharmacoviligance aspects for the future http://t.co/JecluVeAn5 http://t.co/NBxZ7ZAuuY
@claudiavaca5 @carmona_loreto Y algunas recomendaciones para #latam http://t.co/5F7ILUq0tw #Biosimilars
@claudiavaca5 @carmona_loreto Y algunas recomendaciones para #latam http://t.co/5F7ILUq0tw #Biosimilars
Lot of talks about this topic in Rome https://t.co/lLyrdZzhpT #EULAR2015 http://t.co/5F7ILUq0tw
Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a . - PubMed - NCBI http://t.co/CAZEUTlhtD
@IlindelatorreMD @biosimilarz We will have to wait to #EULAR15 Because the embargo policy . Our view http://t.co/qNo7Uz1m9S
@IlindelatorreMD @biosimilarz We will have to wait to #EULAR15 Because the embargo policy . Our view http://t.co/qNo7Uz1m9S
@TatianaAndia @agaviriau Y estas son las recomendaciones para América Latina. Un punto de vista http://t.co/hN4N24EzYE #Biosimilares
Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: http://t.co/tGfUbYYMii vía @researchgate
According to Almetric our article about Recomendations on Biosimilars is doing so well http://t.co/bi5yC47kYj #Thanks http://t.co/L23g1gxF92
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Gran trabajo de @carvicab publicado ya online http://t.co/b02yf2xG6k
Gran trabajo de @carvicab publicado ya online http://t.co/b02yf2xG6k
“@hmbaquero: Gran trabajo de @carvicab publicado ya online http://t.co/bi5yC4oVPR” / Muchas gracias!!! http://t.co/lU279sgolF
Gran trabajo de @carvicab publicado ya online http://t.co/b02yf2xG6k
Gran trabajo de @carvicab publicado ya online http://t.co/b02yf2xG6k
“@carvicab: Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/yqGb9dausV http://t.co/2mQ2KqwqL8”
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
“@carvicab: Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/yqGb9dausV http://t.co/2mQ2KqwqL8”
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO
Very happy. Our article in Clinical Rheumatology on Biosimilars is now on line!!! http://t.co/bi5yC4oVPR http://t.co/j8bK0QWyOO